Malgorzata Nowicka

6PUBLICATIONS
58CO-AUTHORS
Genomics and transcriptomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Rehabilitation engineeringPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 29, 2025
SPEX: A modular end-to-end platform for high-plex tissue spatial omics analysis.

Xiao Li, Ximo Pechuan-Jorge, Tyler Risom

|Apr 14, 2025
Clinical Context Shapes the Relationship between Genomic Alterations and Response to AR Inhibitors and Chemotherapy in Metastatic Prostate Cancer.

Kalpit Shah, Matthew H Secrest, Wei Zhou

|Jan 30, 2024
Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancer.

David Mutch, Athina Voulgari, Xian Marissa Chen

|Feb 02, 2023
Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer.

Carsten Denkert, Chiara Lambertini, Peter A Fasching

|Mar 11, 2022
Circulating Cell-free DNA as a Prognostic Biomarker in Patients with Advanced ALK+ Non-small Cell Lung Cancer in the Global Phase III ALEX Trial.

Rafal Dziadziuszko, Solange Peters, Tony Mok

|Dec 15, 2021
Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer.

Zhen Shi, Julia Wulfkuhle, Malgorzata Nowicka

Pageof 1

Frequent Collaborators

2 joint publications

Matthew Wongchenko

1 joint publications

Rosa I Gallagher

1 joint publications

Cristina Saura

1 joint publications

Paolo G Nuciforo